Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Neurogene Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- +4 vs. Q3 2024
- Shares held
- 16.1M
- +2.29M (+16.6%) vs. Q3 2024
- Total value
- $367.8M
- −$211.2M (−36.5%) vs. Q3 2024
- New holders
- 29
- 30 more added
- Sold out
- 25
- 17 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $544.4M |
| Q1 2026 | 96 | $342.0M |
| Q4 2025 | 93 | $340.4M |
| Q3 2025 | 88 | $265.2M |
| Q2 2025 | 83 | $230.1M |
| Q1 2025 | 86 | $192.8M |
| Q4 2024 | 89 | $367.8M |
| Q3 2024 | 86 | $581.1M |
| Q2 2024 | 66 | $482.7M |
| Q1 2024 | 60 | $617.3M |
| Q4 2023 | 35 | $179.0M |
| Q3 2023 | 31 | $14.4M |
| Q2 2023 | 36 | $14.3M |
| Q1 2023 | 39 | $10.5M |
| Q4 2022 | 46 | $8.66M |
| Q3 2022 | 52 | $12.0M |
| Q2 2022 | 64 | $21.4M |
| Q1 2022 | 81 | $46.3M |
| Q4 2021 | 80 | $118.8M |
| Q3 2021 | 85 | $187.1M |
| Q2 2021 | 82 | $248.8M |
| Q1 2021 | 82 | $341.9M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −22,807−100.0% | Sold out |
| Avoro Capital Advisors LLC | 0 | $0 | 0.00% | −22,029−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −9,980−100.0% | Sold out |
| Stifel Financial Corp | 0 | $0 | 0.00% | −9,249−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −7,050−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −7,717−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −3,576−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −1,279−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −553−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −449−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |